I am perplexed. The product makes sense yet no pathology laboratory is buying it? Is the product dead in the water? If it both saves money and is more reliable than humans, what is the issue?
Is someone with industry inside knowledge able to explain it for me please?
- Forums
- ASX - By Stock
- Ann: LBT RECEIVES $848,673 R&D TAX INCENTIVE
I am perplexed. The product makes sense yet no pathology...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LBT (ASX) to my watchlist
|
|||||
Last
1.5¢ |
Change
0.001(7.14%) |
Mkt cap ! $24.27M |
Open | High | Low | Value | Volume |
1.4¢ | 1.5¢ | 1.4¢ | $6.003K | 424.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1817935 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 1483000 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2532221 | 0.014 |
2 | 5433333 | 0.013 |
4 | 523333 | 0.012 |
4 | 376500 | 0.011 |
3 | 600000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 1433000 | 4 |
0.017 | 1442000 | 4 |
0.018 | 815336 | 6 |
0.019 | 200000 | 1 |
0.020 | 2596000 | 6 |
Last trade - 15.54pm 21/08/2024 (20 minute delay) ? |
Featured News
LBT (ASX) Chart |